Candesartan CREATEs promise in coronary artery disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1614, 2007-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NSAIDs increase CV risk in coronary artery disease

By  

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Celecoxib: beneficial effects in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Roxifiban promising in stable coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Revascularization treatment of stable coronary artery disease

By Magro Michael   Garg Scot   Serruys Patrick W  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 195-212

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for end-stage coronary artery disease

By Sodha Neel R   Chu Louis M   Boodhwani Munir   Sellke Frank W  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite